Evaluation and pharmacologic management of symptoms in cancer patients undergoing acute rehabilitation in a comprehensive cancer center
- PMID: 17601470
- DOI: 10.1016/j.apmr.2007.03.032
Evaluation and pharmacologic management of symptoms in cancer patients undergoing acute rehabilitation in a comprehensive cancer center
Abstract
Objectives: To identify cancer patients' symptoms at admission and on discharge from an acute rehabilitation unit, to document the discharge medications used for symptom management, and to assess how symptoms affect lengths of stay (LOS).
Design: Retrospective chart review.
Setting: Acute inpatient rehabilitation unit within a tertiary cancer center.
Participants: Ninety-six patients (49 men, 47 women) were admitted to an acute inpatient rehabilitation unit. The median age was 64 years (range, 26-87y).
Interventions: Not applicable.
Main outcome measure: Edmonton Symptom Assessment Scale (ESAS) scores at admission and on discharge.
Results: The most intense symptom (mean ESAS visual analog scale score +/- standard deviation) on admission was poor appetite (3.7+/-3.3), followed by fatigue (3.4+/-2.6). Similar results were found for the 63 patients with ESAS scores available at both time points. On discharge, poor appetite (2.2+/-2.4) was still the most intense symptom reported, again followed by fatigue (2.2+/-2.1). There were significant improvements in anxiety (P=.001), constipation (P=.001), fatigue (P=.002), pain (P=.003), appetite (P=.004), sense of well-being (P=.01), and insomnia (P=.04). Seventy percent (65/93) of patients received discharge prescriptions for symptom control, with analgesics being the most frequently prescribed. The poor appetite and depression admission scores correlated positively with hospital LOS (P<.001, P=.05, respectively).
Conclusions: Assessment of symptoms revealed significant symptom burdens in cancer patients undergoing rehabilitation. Pharmacologic interventions for management of symptoms were frequently needed.
Similar articles
-
Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases.J Pain Symptom Manage. 2005 Jul;30(1):18-23. doi: 10.1016/j.jpainsymman.2005.02.009. J Pain Symptom Manage. 2005. PMID: 16043003 Clinical Trial.
-
The association of physical and psychological symptom burden with time to death among palliative cancer outpatients.J Pain Symptom Manage. 2009 Mar;37(3):297-304. doi: 10.1016/j.jpainsymman.2008.03.008. Epub 2008 Aug 9. J Pain Symptom Manage. 2009. PMID: 18694634
-
Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes.J Clin Oncol. 2004 May 15;22(10):2008-14. doi: 10.1200/JCO.2004.11.003. J Clin Oncol. 2004. PMID: 15143094
-
Pharmacological approaches to the treatment of residual symptoms.J Psychopharmacol. 2006 May;20(3 Suppl):29-34. doi: 10.1177/1359786806064325. J Psychopharmacol. 2006. PMID: 16644769 Review.
-
Medications and their effects on sleep.Prim Care. 2005 Jun;32(2):491-509. doi: 10.1016/j.pop.2005.02.009. Prim Care. 2005. PMID: 15935197 Review.
Cited by
-
Changing Paradigms in the Rehabilitation of Inpatients with Brain Tumors.Curr Phys Med Rehabil Rep. 2018 Jun;6(2):115-120. doi: 10.1007/s40141-018-0182-0. Epub 2018 Apr 2. Curr Phys Med Rehabil Rep. 2018. PMID: 29868247 Free PMC article.
-
Sleep aid use during and following breast cancer adjuvant chemotherapy.Psychooncology. 2011 Mar;20(3):321-5. doi: 10.1002/pon.1756. Psychooncology. 2011. PMID: 20878849 Free PMC article. Clinical Trial.
-
Cancer rehabilitation: a barometer for survival?Support Care Cancer. 2015 Oct;23(10):3033-41. doi: 10.1007/s00520-015-2673-1. Epub 2015 Mar 5. Support Care Cancer. 2015. PMID: 25739753
-
Sleep and cancer: recent developments.Curr Oncol Rep. 2008 Jul;10(4):309-18. doi: 10.1007/s11912-008-0049-0. Curr Oncol Rep. 2008. PMID: 18778557 Review.
-
Current practices, gaps, and opportunities on the role of clinical pharmacists in cancer pain management: Perspectives from Nepal.J Oncol Pharm Pract. 2023 Dec;29(8):2049-2056. doi: 10.1177/10781552231205025. Epub 2023 Oct 17. J Oncol Pharm Pract. 2023. PMID: 37847760 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources